{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:07:35Z","timestamp":1781626055069,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johnson + Johnson"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>One out of eight men in the U.S. will be diagnosed\u00a0with prostate cancer during his lifetime. Black men are more likely to be diagnosed with and die from prostate cancer than other males, contributing to significant prostate cancer disparities. Early detection, often by routine screening, allows for more options for treatment and an increased chance of survival. Barriers to screening contribute to prostate cancer disparities, particularly among those who lack regular access to health care. Community based screening programs may overcome barriers to prostate cancer screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An urban, NCI-designated cancer center collaborated with a national prostate cancer advocacy organization to provide free screening to males in our catchment area at local community organizations. Males who were eligible for prostate screening completed a survey about their personal and family history of prostate cancer. A mobile phlebotomist conducted the screenings, consisting of prostate specific antigen (PSA) tests, onsite at the partner agency. Males received a letter with their PSA test results; males with an abnormal result (&gt; 2.5 ng\/mL) also received a phone call. Survey data was analyzed with descriptive statistics and bivariate analyses to assess relationships with PSA test results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two hundred and eighty-nine (\n                      <jats:italic>n<\/jats:italic>\n                      =289) males were screened at a community screening event. The mean age of males screened was 57.3 (SD=11.2) and the majority identified as Black (\n                      <jats:italic>N<\/jats:italic>\n                      =253, 84.9%). The mean PSA test value was 1.82 (SD= 2.70); 18% of males had an abnormal PSA test result. Black males had the highest PSA values of among all men who were screened.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Disparities in prostate cancer, particularly among Black males, warrant interventions like community-based prostate screening events that reduce barriers of cost and access, bringing screening to those who would most benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13690-025-01779-x","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:49:09Z","timestamp":1766573349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the impact of a community-based prostate cancer screening program"],"prefix":"10.1186","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-3631","authenticated-orcid":false,"given":"Amy E.","family":"Leader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatuma","family":"Doka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Kolesnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"DeHoratius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le\u2019Ann","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Giamboy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard G.","family":"Gomella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"1779_CR1","volume-title":"Cancer facts and Figs. 2024","author":"American Cancer Society","year":"2024","unstructured":"American Cancer Society. Cancer facts and Figs. 2024. Atlanta, GA: American Cancer Society; 2024."},{"issue":"6","key":"1779_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877\u201392. https:\/\/doi.org\/10.1016\/j.euo.2021.09.006.","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"1779_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155031","volume":"132","author":"WG Nelson","year":"2022","unstructured":"Nelson WG, Brawley OW, Isaacs WB, et al. Health inequity drives disease biology to create disparities in prostate cancer outcomes. J Clin Invest. 2022;132(3):e155031. https:\/\/doi.org\/10.1172\/JCI155031.","journal-title":"J Clin Invest"},{"issue":"5","key":"1779_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41585-024-00719-1","volume":"21","author":"J Gong","year":"2024","unstructured":"Gong J, Kim DM, Freeman MR, et al. Genetic and biological drivers of prostate cancer disparities in black men. Nat Rev Urol. 2024;21(5):274\u201389. https:\/\/doi.org\/10.1038\/s41585-024-00719-1.","journal-title":"Nat Rev Urol"},{"key":"1779_CR5","unstructured":"United States Preventive Services Task Force. Prostate cancer: Screening. 2018.\u00a0https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prostate-cancer-screening. Accessed\u00a025 Sept 2024."},{"issue":"5","key":"1779_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300289","volume":"3","author":"IP Garraway","year":"2024","unstructured":"Garraway IP, Carlsson SV, Nyame YA, et al. Prostate cancer foundation screening guidelines for Black men in the United States. NEJM Evid. 2024;3(5):EVIDoa2300289. https:\/\/doi.org\/10.1056\/EVIDoa2300289.","journal-title":"NEJM Evid"},{"key":"1779_CR7","unstructured":"American Cancer Society Guidelines for the Early Detection of Cancer. Prostate Cancer Screening Guidelines. Available at: https:\/\/www.cancer.org\/cancer\/screening\/american-cancer-society-guidelines-for-the-early-detection-of-cancer.html. Last accessed 14 Apr 2025."},{"issue":"1","key":"1779_CR8","first-page":"45","volume":"210","author":"JT Wei","year":"2023","unstructured":"Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening. J Urol. 2023;210(1):45\u201353.","journal-title":"J Urol"},{"key":"1779_CR9","unstructured":"National Cancer Institute. National trends progress report: Prostate cancer screening.\u00a0https:\/\/progressreport.cancer.gov\/detection\/prostate_cancer. Accessed\u00a025 Sept 2024."},{"issue":"20","key":"1779_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11202780","volume":"11","author":"S Mumuni","year":"2023","unstructured":"Mumuni S, O\u2019Donnell C, Doody O. The risk factors and screening uptake for prostate cancer: a scoping review. Healthcare. 2023;11(20):2780. https:\/\/doi.org\/10.3390\/healthcare11202780.","journal-title":"Healthcare"},{"issue":"1","key":"1779_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12875-020-01232-3","volume":"21","author":"J Hostetter","year":"2020","unstructured":"Hostetter J, Schwarz N, Klug M, Wynne J, Basson MD. Primary care visits increase utilization of evidence-based preventative health measures. BMC Fam Pract. 2020;21(1):151. https:\/\/doi.org\/10.1186\/s12875-020-01232-3.","journal-title":"BMC Fam Pract"},{"issue":"4","key":"1779_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/cncr.32616","volume":"126","author":"SS Joshi","year":"2020","unstructured":"Joshi SS, Filson CP. Long-term consequences of the USPSTF grade D recommendation for prostate-specific antigen screening. Cancer. 2020;126(4):694\u20136. https:\/\/doi.org\/10.1002\/cncr.32616.","journal-title":"Cancer"},{"issue":"5","key":"1779_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11869","volume":"5","author":"L Burgess","year":"2022","unstructured":"Burgess L, Aldrighetti CM, Ghosh A, et al. Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer-specific mortality. JAMA Netw Open. 2022;5(5):e2211869. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11869.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"1779_CR14","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaoncol.2022.3323","volume":"8","author":"MV Sherer","year":"2022","unstructured":"Sherer MV, Qiao EM, Kotha NV, Qian AS, Rose BS. Association between prostate-specific antigen screening and prostate cancer mortality among non-Hispanic black and non-Hispanic white US veterans. JAMA Oncol. 2022;8(10):1471\u20136. https:\/\/doi.org\/10.1001\/jamaoncol.2022.3323.","journal-title":"JAMA Oncol"},{"key":"1779_CR15","doi-asserted-by":"publisher","unstructured":"Goddard KAB, Feuer EJ, Mandelblatt JS et al. Estimation of cancer deaths averted from prevention, screening, and treatment efforts, 1975\u20132020. JAMA Oncol. 2024:e245381. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5381.","DOI":"10.1001\/jamaoncol.2024.5381"},{"key":"1779_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106242","volume":"141","author":"SK Shah","year":"2020","unstructured":"Shah SK, Nakagawa M, Lieblong BJ. Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: a systematic review. Prev Med. 2020;141:106242. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106242.","journal-title":"Prev Med"},{"issue":"1","key":"1779_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1186\/s12889-021-10764-8","volume":"21","author":"H Alderwick","year":"2021","unstructured":"Alderwick H, Hutchings A, Briggs A, Mays N. The impacts of collaboration between local health care and non-health care organizations and factors shaping how they work: A systematic review of reviews. BMC Public Health. 2021;21(1):753. https:\/\/doi.org\/10.1186\/s12889-021-10764-8.","journal-title":"BMC Public Health"},{"issue":"8","key":"1779_CR18","doi-asserted-by":"publisher","first-page":"e43445","DOI":"10.7759\/cureus.43445","volume":"15","author":"S Kale","year":"2023","unstructured":"Kale S, Hirani S, Vardhan S, et al. Addressing cancer disparities through community engagement: lessons and best practices. Cureus. 2023;15(8):e43445. https:\/\/doi.org\/10.7759\/cureus.43445.","journal-title":"Cureus"},{"issue":"5","key":"1779_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3322\/caac.21790","volume":"73","author":"AR Korn","year":"2023","unstructured":"Korn AR, Walsh-Bailey C, Correa-Mendez M, et al. Social determinants of health and US cancer screening interventions: A systematic review. CA Cancer J Clin. 2023;73(5):461\u201379. https:\/\/doi.org\/10.3322\/caac.21790.","journal-title":"CA Cancer J Clin"},{"key":"1779_CR20","doi-asserted-by":"publisher","unstructured":"Lopez A, Bailey JT, Galloway D et al. Evidence-based prostate cancer screening interventions for black men: A systematic review. J Racial Ethn Health Disparities. 2024. https:\/\/doi.org\/10.1007\/s40615-024-02100-2.","DOI":"10.1007\/s40615-024-02100-2"},{"key":"1779_CR21","unstructured":"U.S. Census Bureau.\u00a0American Community Survey 1-year estimates. Retrieved from Census Reporter Profile page for Philadelphia-Camden-Wilmington, PA-NJ-DE-MD Metro Area. 2023. Available at: http:\/\/censusreporter.org\/profiles\/31000US37980-philadelphia-camden-wilmington-pa-nj-de-md-metro-area\/. Last accessed\u00a022 Jul 2025."},{"key":"1779_CR22","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. State Cancer Profiles. Available at: https:\/\/www.statecancerprofiles.cancer.gov\/incidencerates\/. Last accessed\u00a022 Jul 2025."},{"key":"1779_CR23","unstructured":"Prostate Conditions Education Council.\u00a0https:\/\/www.prostateconditions.org. Accessed\u00a025 Sept 2024."},{"key":"1779_CR24","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and, Medicine. Advancing Progress in Cancer Prevention and Risk Reduction: Proceedings of a Workshop. Washington, DC: National Academies Press; 2023. https:\/\/doi.org\/10.17226\/27026.","DOI":"10.17226\/27026"},{"issue":"8","key":"1779_CR25","first-page":"879","volume":"99","author":"DH Suite","year":"2007","unstructured":"Suite DH, La Bril R, Primm A, Harrison-Ross P. Beyond misdiagnosis, misunderstanding and mistrust: relevance of the historical perspective in the medical and mental health treatment of people of color. J Natl Med Assoc. 2007;99(8):879\u201385.","journal-title":"J Natl Med Assoc"},{"issue":"9","key":"1779_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1037\/hea0000368","volume":"35","author":"AG Cuevas","year":"2016","unstructured":"Cuevas AG, O\u2019Brien K, Saha S. African American experiences in healthcare: I always feel like i\u2019m getting skipped over. Health Psychol. 2016;35(9):987\u201395. https:\/\/doi.org\/10.1037\/hea0000368.","journal-title":"Health Psychol"},{"issue":"2","key":"1779_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41391-023-00585-2","volume":"26","author":"M Barlow","year":"2023","unstructured":"Barlow M, Down L, Mounce LTA, et al. Ethnic differences in prostate-specific antigen levels in men without prostate cancer: A systematic review. Prostate Cancer Prostatic Dis. 2023;26(2):249\u201356. https:\/\/doi.org\/10.1038\/s41391-023-00585-2.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1779_CR28","first-page":"1323","volume":"9","author":"RE Myers","year":"2000","unstructured":"Myers RE, Hyslop T, Jennings-Dozier K, et al. Intention to be tested for prostate cancer risk among African American men. Cancer Epidemiol Biomarkers Prev. 2000;9:1323\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-025-01779-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:43:40Z","timestamp":1781624620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13690-025-01779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1779"],"URL":"https:\/\/doi.org\/10.1186\/s13690-025-01779-x","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, the study was approved by the Institutional Review Board at Thomas Jefferson University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}